Sedana Medical AB (publ)

BATS-CHIXE:SEDANS Stock Report

Market Cap: SEK 2.3b

Sedana Medical Past Earnings Performance

Past criteria checks 0/6

Sedana Medical's earnings have been declining at an average annual rate of -22.8%, while the Medical Equipment industry saw earnings declining at 1.9% annually. Revenues have been growing at an average rate of 12.2% per year.

Key information

-22.8%

Earnings growth rate

-20.2%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate12.2%
Return on equity-4.3%
Net Margin-24.6%
Next Earnings Update24 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sedana Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:SEDANS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24169-4115421
31 Mar 24165-2315421
31 Dec 23154-6015521
30 Sep 23145-5716020
30 Jun 23137-5816920
31 Mar 23127-7117020
31 Dec 22123-7417020
30 Sep 22133-5417121
30 Jun 22135-6215621
31 Mar 22148-6815321
31 Dec 21159-5814820
30 Sep 21159-5313616
30 Jun 21152-5112813
31 Mar 21153-3811411
31 Dec 20142-271028
30 Sep 20116-227813
30 Jun 20111-147211
31 Mar 2088-12638
31 Dec 1972-16567
30 Sep 1967-13610
30 Jun 1963-11550
31 Mar 1960-10510
31 Dec 1858-7470
30 Sep 1853-3430
30 Jun 1851-4410
31 Mar 1847-3370
31 Dec 1742-4320
30 Sep 1741-3300
30 Jun 17390280
31 Mar 17360240
31 Dec 16341220
31 Dec 1528-1180

Quality Earnings: SEDANS is currently unprofitable.

Growing Profit Margin: SEDANS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SEDANS is unprofitable, and losses have increased over the past 5 years at a rate of 22.8% per year.

Accelerating Growth: Unable to compare SEDANS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SEDANS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).


Return on Equity

High ROE: SEDANS has a negative Return on Equity (-4.27%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies